PK, PD and Safety of Tegoprazan 12.5 mg After Oral Administration in Healthy Subjects

Conditions: Healthy Interventions: Drug: Tegoprazan 12.5mg; Drug: Tegoprazan 25mg; Drug: Famotidine 20mg Sponsors: HK inno.N Corporation Enrolling by invitation

https://clinicaltrials.gov/study/NCT06332638

Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials

More News: Famotidine | Research